vimarsana.com

Page 29 - பல்கலைக்கழகம் ஆஃப் விஸ்கான்சின் பள்ளி மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ultrasound technique treats prostate cancer with minimal side effects

 E-Mail IMAGE: Images in 69-year-old man with biopsy-confirmed Gleason score 7 (3+4) prostate cancer. (a) Pretreatment axial T2-weighted fast spin-echo MRI scan (repetition time msec/echo time msec, 3820/97) shows tumor in midline. view more  Credit: Radiological Society of North America OAK BROOK, Ill. - A technique that delivers high-intensity focused ultrasound to targeted tissue under MRI guidance effectively treats intermediate-risk prostate cancer with minimal side effects, according to a study published in Radiology. Prostate cancer is the most common cancer among men, aside from non-melanoma skin cancers. Common treatments to the entire gland, such as surgery and radiation therapy, are effective in eliminating the cancer, but they often leave patients with incontinence and sexual dysfunction.

Research news tip sheet: Story ideas from Johns Hopkins Medicine

Diabetic retinopathy a disorder characterized by damage to the small blood vessels lining the retina (light-focusing area) of the eye and a leading cause of vision loss worldwide has been on the rise in recent years as the number of children and adolescents diagnosed with either type 1 or type 2 diabetes increases. Although the American Diabetes Association (ADA) advises regular screening for pediatric diabetic retinopathy, it s estimated that fewer than half of all youth with diabetes follow the recommendation. Without early detection and treatment, these patients put themselves at risk for serious vision problems or blindness as they get older.

One-Shot COVID-19 Vaccine Prevents Severe Disease

Johnson & Johnson s vaccine is less effective at preventing COVID-19 than other approved vaccines are, but experts say it could still be an important tool in curbing the pandemic.

Single-shot Johnson & Johnson vaccine 66 percent effective against moderate and severe illness

Single-shot Johnson & Johnson vaccine 66 percent effective against moderate and severe illness
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.